drugset / Trial / NCT04670289

Safety, Tolerability, and Pharmacokinetics of Single Dose TenoMiR as a Treatment for Tennis Elbow

NCT04670289 ↗

Phase 1 Completed 24 enrolled Causeway Therapeutics
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is testing a drug called TenoMiR that is being developed for the treatment of tennis elbow (lateral epicondylitis). The study drug is a new compound that works by improving the quality of the collagen which helps repair damage to the elbow. The study drug is being developed in the hope of providing a more reliable treatment than those currently available and can be given at the time of first diagnosis, so that recovery can begin as soon as possible.

Timeline

Start
2020-08-14
Primary completion
2021-05-19
Completion
2021-08-18

Drugs

EvaluationDrugModalityDoseRoute
Subject TenoMiR Oligonucleotide (other) — Other

Indications